Humoral response to mRNA‐based COVID‐19 vaccine in patients with myeloid malignancies

Data on the response to the COVID‐19 vaccine in patients with myeloid malignancy, who are at severe risk in case of infection, have not emerged. In a study of 69 patients with myeloid malignancies, including 46 patients with acute myeloid leukaemia (AML) and 23 patients with myelodysplastic syndrome...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Akio, Onozawa, Masahiro, Tsukamoto, Shihori, Ishio, Takashi, Yokoyama, Emi, Izumiyama, Koh, Saito, Makoto, Muraki, Haruna, Morioka, Masanobu, Teshima, Takanori, Kondo, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Covid‐19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111452/
https://www.ncbi.nlm.nih.gov/pubmed/35226358
http://dx.doi.org/10.1111/bjh.18138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111452/
https://www.ncbi.nlm.nih.gov/pubmed/35226358
http://dx.doi.org/10.1111/bjh.18138

Ejemplares similares